Air Products & Chemicals, Inc.: Form 10-K for the period ended Sep 30, 2017
Filed with the SEC on Nov 16, 2017 and accepted by EDGAR at Nov 16, 2017, 08:20 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 12 months2016-10-01 to 2017-09-30 | $5.75bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2017-07-01 to 2017-09-30 | $657.8m | us-gaap:GrossProfit |
| Gross profit | 12 months2016-10-01 to 2017-09-30 | $2.43bn | us-gaap:GrossProfit |
| Research and development | 12 months2016-10-01 to 2017-09-30 | $57.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2016-10-01 to 2017-09-30 | $715.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-07-01 to 2017-09-30 | $455.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2016-10-01 to 2017-09-30 | $1.43bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2016-10-01 to 2017-09-30 | $120.6m | us-gaap:InterestExpense |
| Income tax | 3 months2017-07-01 to 2017-09-30 | −$1.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 12 months2016-10-01 to 2017-09-30 | $260.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-07-01 to 2017-09-30 | $468.7m | us-gaap:NetIncomeLoss |
| Net income | 12 months2016-10-01 to 2017-09-30 | $3.00bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-07-01 to 2017-09-30 | $2.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2016-10-01 to 2017-09-30 | $13.65 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-07-01 to 2017-09-30 | $2.15 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2016-10-01 to 2017-09-30 | $13.76 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2016-10-01 to 2017-09-30 | 219,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2016-10-01 to 2017-09-30 | $2.53bn | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2016-10-01 to 2017-09-30 | $1.04bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2016-10-01 to 2017-09-30 | $787.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2017-09-30 | $3.27bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-09-30 | $5.88bn | us-gaap:AssetsCurrent |
| Total assets | At period end2017-09-30 | $18.47bn | us-gaap:Assets |
| Current liabilities | At period end2017-09-30 | $2.49bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-09-30 | $8.28bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2017-09-30 | $144.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2017-09-30 | $10.09bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000002969-17-000039. Last ingested by Listed: Nov 5, 2026, 11:28 ET. Listed shows no prices and gives no investment advice.